Charles Ryan

Emailryancumnedu

Research activity per year

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Fingerprint

The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

1 Similar Profiles

4 Active
14 Finished

Prostate Cancer Research Program, Clinical Consortium Award: University of Minnesota Masonic Cancer Center
Antonarakis, E. (PI) & Ryan, C. (CoI)
US DEPT OF DEFENSE ARMY
9/30/22 → 9/29/26
Project: Research project
A Phase 1, Dose Escalation Study of JNJ-75229414, a Chimeric Antigen Receptor T cell(CAR-T) Therapy Directed Against KLK2 for Metastatic Castration-Resistant ProstateCancer
Ryan, C. (PI)
JANSSEN RESEARCH & DEVELOPMENT, LLC
7/1/21 → 6/30/26
Project: Research project
A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Antonarakis, E. (PI), Rao, A. (Prior Principal Investigator) & Ryan, C. (Prior Principal Investigator)
ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY, JANSSEN PHARMACEUTICALS, INC.
4/1/18 → 4/30/26
Project: Research project
A Phase III Randomized Trial Comparing Androgen Deprivat
Ryan, C. (PI) & Gupta, S. (Prior Principal Investigator)
BRIGHAM AND WOMEN'S HOSPITAL, NIH NATIONAL CANCER INSTITUTE
7/30/15 → 12/31/27
Project: Research project
AR Alternative Polyadenylation as a Therapeutic Vulnerability in Prostate Cancer
Tietz, K. T. (PI), Dehm, S. M. (CoI) & Ryan, C. (CoI)
U.S. DEPARTMENT OF DEFENSE
9/1/22 → 8/31/25
Project: Research project

184 Article
51 Review article
7 Comment/debate
4 Editorial
More
- 4 Letter
- 2 Chapter

Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting
Lozada, J. R., Elliott, A., Evans, M. G., Wacker, J., Storey, K. M., Egusa, E. A., Zorko, N. A., Kumar, A., Crymes, A., Heath, E. I., Carneiro, B. A., Soares, H. P., Cichocki, F. M., Miller, J. S., Lou, E., Beltran, H., Antonarakis, E. S., Ryan, C. & Hwang, J., Feb 1 2025, In: Cancer Research Communications. 5, 2, p. 318-326 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
3 Scopus citations
HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers
Vobugari, N., Makovec, A., Kellen, S., Nazari, S. S., Elliott, A., Schmeck, D., Deacon, A., von Dohlen, G., John, E., Barata, P. C., Agarwal, N., Geller, M. A., Erickson, B. K., Sledge, G., Ostrander, J. H., McKay, R. R., Ryan, C. J., Sharifi, N., Antonarakis, E. S. & Hwang, J., Jun 2025, In: International journal of molecular sciences. 26, 12, 5720.
Research output: Contribution to journal › Article › peer-review

Open Access
Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024
Bryce, A. H., Agarwal, N., Beltran, H., Hussain, M. H., Sartor, O., Shore, N., Antonarakis, E. S., Armstrong, A. J., Calais, J., Carducci, M. A., Dorff, T. B., Efstathiou, J. A., Gleave, M., Gomella, L. G., Higano, C., Hope, T. A., Iagaru, A., Morgans, A. K., Morris, D. S. & Morris, M. J. & 14 others, Petrylak, D. P., Reiter, R. E., Rettig, M. B., Ryan, C. J., Sellinger, S. B., Spratt, D. E., Srinivas, S., Tagawa, S. T., Taplin, M. E., Yu, E. Y., Zhang, T., McKay, R. R., Koo, P. J. & Crawford, E. D., Jan 1 2025, In: Cancer. 131, 1, e35612.
Research output: Contribution to journal › Article › peer-review

Open Access
5 Scopus citations
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
Gillessen, S., Turco, F., Davis, I. D., Efstathiou, J. A., Fizazi, K., James, N. D., Shore, N., Small, E., Smith, M., Sweeney, C. J., Tombal, B., Zilli, T., Agarwal, N., Antonarakis, E. S., Aparicio, A., Armstrong, A. J., Bastos, D. A., Attard, G., Axcrona, K. & Ayadi, M. & 101 others, Beltran, H., Bjartell, A., Blanchard, P., Bourlon, M. T., Briganti, A., Bulbul, M., Buttigliero, C., Caffo, O., Castellano, D., Castro, E., Cheng, H. H., Chi, K. N., Clarke, C. S., Clarke, N., de Bono, J. S., De Santis, M., Duran, I., Efstathiou, E., Ekeke, O. N., El Nahas, T. I. H., Emmett, L., Fanti, S., Fatiregun, O. A., Feng, F. Y., Fong, P. C. C., Fonteyne, V., Fossati, N., George, D. J., Gleave, M. E., Gravis, G., Halabi, S., Heinrich, D., Herrmann, K., Hofman, M. S., Hope, T. A., Horvath, L. G., Hussain, M. H. A., Jereczek-Fossa, B. A., Jones, R. J., Joshua, A. M., Kanesvaran, R., Keizman, D., Khauli, R. B., Kramer, G., Loeb, S., Mahal, B. A., Maluf, F. C., Mateo, J., Matheson, D., Matikainen, M. P., McDermott, R., McKay, R. R., Mehra, N., Merseburger, A. S., Morgans, A. K., Morris, M. J., Mrabti, H., Mukherji, D., Murphy, D. G., Murthy, V., Mutambirwa, S. B. A., Nguyen, P. L., Oh, W. K., Ost, P., O'Sullivan, J. M., Padhani, A. R., Parker, C., Poon, D. M. C., Pritchard, C. C., Rabah, D. M., Rathkopf, D., Reiter, R. E., Renard-Penna, R., Ryan, C. J., Saad, F., Sade, J. P., Sandhu, S., Sartor, O. A., Schaeffer, E., Scher, H. I., Sharifi, N., Skoneczna, I. A., Soule, H. R., Spratt, D. E., Srinivas, S., Sternberg, C. N., Suzuki, H., Taplin, M. E., Thellenberg-Karlsson, C., Tilki, D., Türkeri, L. N., Uemura, H., Ürün, Y., Vale, C. L., Vapiwala, N., Walz, J., Yamoah, K., Ye, D., Yu, E. Y., Zapatero, A. & Omlin, A., Feb 2025, In: European Urology. 87, 2, p. 157-216 60 p.
Research output: Contribution to journal › Article › peer-review

Open Access
54 Scopus citations
Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer
Halabi, S., Guo, S., Luo, B., Yu, C., Knutson, T. P., Kobilka, A. C., Lyman, J. A., Beltran, H., Antonarakis, E. S., Galsky, M. D., Rosenberg, J. E., Ryan, C., Small, E. J., Kelly, W. K., Morris, M. J., Page, D., Dehm, S. M. & Armstrong, A. J., 2025, (Accepted/In press) In: European Urology.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations

Cancer death rates are going down. Is prostate cancer an exception?
Ryan, C.
2/4/20
1 item of Media coverage
Press/Media: Expert Comment or Interview

Charles Ryan

Personal profile

Expertise related to UN Sustainable Development Goals

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Prostate Cancer Research Program, Clinical Consortium Award: University of Minnesota Masonic Cancer Center

A Phase 1, Dose Escalation Study of JNJ-75229414, a Chimeric Antigen Receptor T cell(CAR-T) Therapy Directed Against KLK2 for Metastatic Castration-Resistant ProstateCancer

A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

A Phase III Randomized Trial Comparing Androgen Deprivat

AR Alternative Polyadenylation as a Therapeutic Vulnerability in Prostate Cancer

Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting

HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers

Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer

Cancer death rates are going down. Is prostate cancer an exception?

Charles Ryan

Personal profile

Expertise related to UN Sustainable Development Goals

Fingerprint

Collaborations and top research areas from the last five years

Projects

Research output

Press/Media